Epidemiology of cannabidiol related cases reported in the National Poison Data System – 2019-2020

Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

Orrin Devinsky, Anup D. Patel, J. Helen Cross et al. · New England Journal of Medicine · 2018 · 977 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

Orrin Devinsky, Eric D. Marsh, Daniel J. Friedman et al. · The Lancet Neurology · 2015 · 895 citations

Medicine, Pharmacology, Pharmacotherapy +13

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial

Philip McGuire, Philip Robson, D. Vasile et al. · American Journal of Psychiatry · 2017 · 616 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

Labeling Accuracy of Cannabidiol Extracts Sold Online

Marcel O. Bonn‐Miller, Mallory Loflin, Brian F. Thomas et al. · JAMA · 2017 · 530 citations · Full text

Pharmacy, Pharmaceutical Analysis, Regulatory Pharmacy +11

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects

Lesley Taylor, Barry E. Gidal, Graham Blakey et al. · CNS Drugs · 2018 · 464 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16